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Lessons from a case of academic misconduct
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On 19 September 2018, three JAMA journals retracted
publications of six studies that had Brian Wansink, John Dyson
professor of marketing at Cornell University, as an author.1 This
adds to seven previous retractions of his work, making a total
of 13 articles retracted as of 10 October2; others may follow.
Many of the problems in the retracted studies came to light
when a small group of researchers carried out detailed analysis
of several articles coauthored by Wansink.3 A subsequent
investigation by Cornell found that Wansink committed
academic misconduct, including “misreporting of research data,
problematic statistical techniques, failure to properly document
and preserve research results, and inappropriate authorship.”4
This raises concerns of—at the least—endemic sloppiness
and—at worst—a disproportionate focus on creating compelling
narratives rather than establishing firm observations.
Such academic misconduct damages trust in science and
scientists, and this may be particularly marked in the Wansink
case given his profile outside academia. His work, encapsulated
in the book Mindless Eating, influenced wider scientific, policy,
and public discourse about how the food environment can be
altered to change our behaviour. He was executive director of
the USDA Center for Nutrition Policy and Promotion from 2007
to 2009, where he led revision of the 2010 Dietary Guidelines
for America, and the Smarter Lunchrooms strategies he devised
are currently being used in over 29 000 schools.
His studies have been included in countless narrative and
systematic reviews, raising the question of the extent to which
the retraction of 13 of his studies undermines evidence in this
field. For example, two Cochrane reviews for which two of us
(GJH and TMM) are authors, one on the effect of portion,
package, and tableware size5 and the other on nutritional
labelling,6 include studies by Wansink. None of the included
studies has been retracted, leaving the reviews’ results and
conclusions unchanged. But the retractions raise questions about
the veracity of other studies Wansink has authored.
It is tempting to treat this as an isolated case, but retractions are
not uncommon and are increasing in frequency, although
whether this reflects increased detection or prevalence is
unknown.7 Unfortunately, the responses of institutions to cases
such as that of Wansink tend to focus on allocating blame,
avoiding litigation, and ultimately hoping that the whole thing
will blow over. What is lacking is serious reflection by
institutions—universities, funders, and journal editors—on the
systemic aspects of their cultures and practices that might have
contributed to the problem in the first place. This is in stark
contrast to the aviation industry, which has an enviable safety
record: when a disaster occurs, it is forensically examined not
only to identify its proximal cause but also the wider system
that allowed it to happen.
The NHS is beginning to learn from the aviation industry,8 but
universities are lagging behind. Some of the institutional
processes that may contribute to questionable research practices,
which in extreme cases can extend to outright fraud, are clear.
For example, institutions may shape the behaviour of scientists
in ways that have unintended consequences by
disproportionately rewarding publication and grant income over
robust observations.
What can we do? Open research practices provide the research
community—including researchers, universities, funders, and
journal editors—with a framework for minimising academic
misconduct of the kind perpetrated by Wansink.7 Individual
researchers can protect themselves against their own enthusiasm,
and the incentives to discover something, by preregistering their
study protocols and analysis plans. Journals and funders could
also require preregistration of study protocols and mandate data
sharing, not just for clinical trials but across research areas and
methods. There may be cases where this is not appropriate, but
in general, making research workflows transparent and subject
to potential scrutiny should serve as a quality control measure,
including ensuring data are thoroughly checked. Institutions
could encourage open research practices by including these as
criteria in job descriptions, supported by training in these
approaches.
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Ultimately what is required is a cultural change. None of
Wansink’s retracted articles was single authored. Should the
coauthors bear some responsibility for not identifying and
highlighting concerns? The recommendations of the
International Committee of Medical Journal Editors state that
all authors should be “accountable for all aspects of the work.”9
In practice, however, this is complicated by the realities of long
distance international collaborations, specific technical
contributions of individual authors, and, critically, hierarchies
and power structures that can make it difficult for junior
researchers to speak out if they feel concerned about the work
of more senior authors.
There is no “one size fits all” solution that will apply across
disciplines, but the culture of many parts of the research
ecosystem needs to change if biomedical science is to have a
record for reliability closer to that of the aviation industry.
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